Noam Danenberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Wize Pharma set for switch to Bitcoin mining Wize Pharma has spun off its ophthalmology drug development activities, and will begin to mine digital currencies in another month through Cosmos. Wize Pharma (OTCQB: WIZP), from Hod Hasharon, has reported that it has met all the preconditions for implementing the offer to purchase the shares of Australian bitcoin miner Cosmos Capital Ltd. Wize Pharma expects to complete the purchase of the shares by March 9, 2021. One of the conditions was that the level of response should be a minimum of 90% of Cosmos shareholders, and as of yesterday a response ...

Wize Pharma's Takeover Offer for Cosmos Capital Declared Unconditional USA - English News provided by Share this article Share this article HOD HASHARON, Israel, Feb. 16, 2021 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced that it has declared its previously announced off-market takeover offer ("Offer") for all of the ordinary shares in Cosmos Capital Limited, a leading digital infrastructure provider based in Sydney, Australia ("Cosmos"), free from all of the conditions set out in t...

Wize Pharma merges with Australian Bitcoin miner Cosmos The Israeli biopharmaceutical company will spin off its drug development activity and focus on Bitcoin mining. Israeli clinical stage biopharmaceutical company Wize Pharma Inc. (OTCQB: WIZP) will merge with privately-held Australian digital currency infrastructure provider Cosmos Capital, in an all share deal, which will ultimately leave Cosmos's shareholders owning most of Wize's shares. Wize, which is controlled by Rimon Gold, the investment arm of serial entrepreneur Yair Goldfinger, US investor Jonathan Rubini, and its CEO Noam Danen...

Wize Pharma and Cosmos Capital enter into Bid Implementation Agreement USA - English - Cosmos Capital, a digital infrastructure provider, to become publicly traded through a business combination with Wize - The combined company is expected to have approximately US$5 million in cash and cash equivalents at closing News provided by Share this article HOD HASHARON, Israel, and SYDNEY, Dec. 30, 2020 /PRNewswire/ --  Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, and Cosmos Capital Limited, a leading digital infrastruc...